Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

335.68
Delayed Data
As of Oct 16
 -1.96 / -0.58%
Today’s Change
244.28
Today|||52-Week Range
344.37
+28.51%
Year-to-Date

Today’s Trading

Previous close337.64
Today’s open337.73
Day’s range333.17 - 344.37
Volume1,176,589
Average volume (3 months)1,359,960
Market cap$71.4B
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+6.28%
Earnings growth (next 5 years)+5.71%
Revenue growth (last year)+9.37%
P/E ratio22.0
Price/Sales6.09
Price/Book6.00

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-0.69-0.33%
GILDGilead Sciences-1.22-1.50%
----
BIVVBioverativ Inc+0.50+0.85%
Data as of 10/16/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$5.68
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts